ADRA1D Antikörper (N-Term)

Produktnummer ABIN1945085

Der Kaninchen Polyklonal Anti-ADRA1D-Antikörper wurde für WB, IHC (p) und FACS validiert. Er ist geeignet, ADRA1D in Proben von Human und Ratte zu detektieren. Es sind 5+ Publikationen verfügbar.

Kurzübersicht für ADRA1D Antikörper (N-Term) (ABIN1945085)

Target: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ADRA1D Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Klon: RB46798

Produktdetails anti-ADRA1D Antikörper

Bindungsspezifität: AA 1-30, N-Term

Homologie: M, Rb, B, Dog, Sh

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This ADRA1D antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-30amino acids from the N-terminal region of human ADRA1D.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. IHC-P: 1:25. IHC-P: 1:25. IHC-P: 1:25. FC: 1:25

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-ADRA1D Antikörper (ABIN1945085)

Schwinn, Johnston, Page, Mosley, Wilson, Worman, Campbell, Fidock, Furness, Parry-Smith: "Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues." in: The Journal of pharmacology and experimental therapeutics, Vol. 272, Issue 1, pp. 134-42, (1995) (PubMed).

Esbenshade, Hirasawa, Tsujimoto, Tanaka, Yano, Minneman, Murphy: "Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells." in: Molecular pharmacology, Vol. 47, Issue 5, pp. 977-85, (1995) (PubMed).

Forray, Bard, Wetzel, Chiu, Shapiro, Tang, Lepor, Hartig, Weinshank, Branchek: "The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype." in: Molecular pharmacology, Vol. 45, Issue 4, pp. 703-8, (1994) (PubMed).

Weinberg, Trivedi, Tan, Mitra, Perkins-Barrow, Borkowski, Strader, Bayne: "Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c." in: Biochemical and biophysical research communications, Vol. 201, Issue 3, pp. 1296-304, (1994) (PubMed).

Bruno, Whittaker, Song, Berelowitz: "Molecular cloning and sequencing of a cDNA encoding a human alpha 1A adrenergic receptor." in: Biochemical and biophysical research communications, Vol. 179, Issue 3, pp. 1485-90, (1991) (PubMed).

Details zu ADRA1D

Target: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Andere Bezeichnung: ADRA1D

Hintergrund: This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.

Molekulargewicht: 60463

Gen-ID: 146

UniProt: P25100